Ligands of purinergic receptors as novel analgesics
- Authors: Vassilevski A.A1,2
-
Affiliations:
- Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS
- Future Analgesics Ltd
- Issue: Vol 14, No 3 (2019)
- Pages: 76-76
- Section: Articles
- Submitted: 16.01.2023
- Published: 15.09.2019
- URL: https://genescells.ru/2313-1829/article/view/122365
- DOI: https://doi.org/10.23868/gc122365
- ID: 122365
Cite item
Abstract
Full Text
About the authors
A. A Vassilevski
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS; Future Analgesics Ltd
Email: avas@ibch.ru
Moscow, Russia
References
- Grishin E.V., Savchenko G.A., Vassilevski A.A. et al. Novel peptide from spider venom inhibits P2X3 receptors and inflammatory pain. Ann. Neurol. 2010; 67(5): 680-3.
- Kabanova N.V., Vassilevski A.A., Rogachevskaja O.A. et al. Modulation of P2X3 receptors by spider toxins. Biochim. Biophys. Acta 2012; 1818(11): 2868-75.
- Oparin P.B., Nadezhdin K.D., Berkut A.A. et al. Structure of purotoxin-2 from wolf spider: modular design and membrane-assisted mode of action in arachnid toxins. Biochem. J. 2016; 473(19): 3113-26.